•
Sep 30, 2024

SIGA Technologies Q3 2024 Earnings Report

SIGA Technologies reported financial results for Q3 2024, marked by increased product sales and significant procurement orders.

Key Takeaways

SIGA Technologies reported a profitable third quarter, driven by a $122 million in procurement orders, including a major order for oral TPOXX. The company is positioned for substantial revenue in Q4 2024 and 2025, with $146 million in outstanding orders.

SIGA received $122 million in procurement orders during the third quarter.

A $112.5 million order for oral TPOXX was received under the 19C BARDA contract.

The company had approximately $146 million of outstanding procurement orders as of September 30, 2024.

Deliveries related to the $112.5 million order began in late September and continued into October.

Total Revenue
$10M
Previous year: $9.24M
+8.4%
EPS
$0.02
Previous year: -$0.01
-300.0%
Gross Profit
$8.39M
Previous year: $4.69M
+78.9%
Cash and Equivalents
$99.3M
Previous year: $71.1M
+39.6%
Free Cash Flow
-$7.41M
Previous year: -$5.1M
+45.2%
Total Assets
$195M
Previous year: $158M
+23.3%

SIGA Technologies

SIGA Technologies

SIGA Technologies Revenue by Segment

Forward Guidance

SIGA Technologies is focused on diversifying its revenue base, enhancing shareholder value, advancing development programs, continuing its public health mission and preparing to negotiate the next contract with the U.S. Government.

Revenue & Expenses

Visualization of income flow from segment revenue to net income